Cargando…

Malondialdehyde in benign prostate hypertrophy: a useful marker?

Benign prostate hypertrophy (BPH) is the most common benign tumor in men due to obstruction of the urethra and, finally, uremia. Malondialdehyde (MDA) is a product derived from peroxidation of polyunsaturated fatty acids and related esters. Evaluation of MDA in serum represents a non-invasive biomar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Merendino, Rosaria Alba, Salvo, Francesco, Saija, Antonella, Di Pasquale, Giuseppe, Tomaino, Antonio, Minciullo, Paola Lucia, Fraccica, Giuseppe, Gangemi, Sebastiano
Formato:	Texto
Lenguaje:	English
Publicado:	2003
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781597/ https://www.ncbi.nlm.nih.gov/pubmed/12775364 http://dx.doi.org/10.1080/0962935031000097745

Ejemplares similares

Interleukin-18 and CD30 serum levels in patients with moderate-severe depression.
por: Merendino, Rosaria Alba, et al.
Publicado: (2002)

Malondialdehyde as a Potential Oxidative Stress Marker for Allergy-Oriented Diseases: An Update
por: Cordiano, Raffaele, et al.
Publicado: (2023)

Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index.
por: Di Lorenzo, Gabriele, et al.
Publicado: (2003)

Protein carbonyl group content in patients affected by familiar chronic nail candidiasis.
por: Gangemi, S, et al.
Publicado: (2003)

Oxidative stress markers in patients with hereditary angioedema
por: Del Giacco, Stefano R., et al.
Publicado: (2017)

Lipid peroxidation and protein oxidation in patients affected by Hodgkin's lymphoma.
por: Morabito, F, et al.
Publicado: (2004)

Effect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease.
por: Gangemi, Sebastiano, et al.
Publicado: (2003)

Age-Related Modifications in Circulating IL-15 Levels in Humans
por: Gangemi, Sebastiano, et al.
Publicado: (2005)

Modification of Interleukin-15 Serum Levels in Workers Exposed to Chemotherapeutic Agents
por: Spatari, Giovanna, et al.
Publicado: (2005)

Involvement of new oxidative stress markers in chronic spontaneous urticaria
por: Nettis, Eustachio, et al.
Publicado: (2017)

Involvement of fractalkine and macrophage inflammatory protein-1 alpha in moderate-severe depression.
por: Merendino, Rosaria Alba, et al.
Publicado: (2004)

Cytokine Network Involvement in Subjects Exposed to Benzene
por: Minciullo, Paola Lucia, et al.
Publicado: (2014)

Different clinical allergological features of Taenia solium infestation
por: Minciullo, Paola Lucia, et al.
Publicado: (2016)

Flare Up Reaction During Provocation Test to Glatiramer Acetate in a Patient With Allergy to Interferon Beta1a
por: Minciullo, Paola L., et al.
Publicado: (2014)

Unmet diagnostic needs in contact oral mucosal allergies
por: Minciullo, Paola Lucia, et al.
Publicado: (2016)

ATAK Complex (Adrenaline, Takotsubo, Anaphylaxis, and Kounis Hypersensitivity-Associated Coronary Syndrome) after COVID-19 Vaccination and Review of the Literature
por: Minciullo, Paola Lucia, et al.
Publicado: (2023)

Drug induced Kounis syndrome: does oxidative stress play a role?
por: Ricciardi, Luisa, et al.
Publicado: (2018)

PPI adverse drugs reactions: a retrospective study
por: Casciaro, Marco, et al.
Publicado: (2019)

Involvement of miR-142 and miR-155 in Non-Infectious Complications of CVID
por: Amato, Giuliana, et al.
Publicado: (2020)

The soft computing-based approach to investigate allergic diseases: a systematic review
por: Tartarisco, Gennaro, et al.
Publicado: (2017)

Doxazosin in the treatment of benign prostatic hypertrophy: an update
por: Wilt, Timothy J, et al.
Publicado: (2006)

Update on the use of dutasteride in the management of benign prostatic hypertrophy
por: Miller, Joe, et al.
Publicado: (2007)

Surgical therapy for benign prostatic hypertrophy/bladder outflow obstruction
por: Thiruchelvam, Nikesh
Publicado: (2014)

Prostate Artery Embolization for Complete Urinary Outflow Obstruction Due to Benign Prostatic Hypertrophy
por: Yu, Simon Chun Ho, et al.
Publicado: (2016)

Improving Whole Tomato Transformation for Prostate Health: Benign Prostate Hypertrophy as an Exploratory Model
por: Natali, Pier Giorgio, et al.
Publicado: (2023)

AB101. Diversity and choice in the surgical techniques for benign prostatic hypertrophy
por: He, Leye
Publicado: (2015)

In-silico and in-vivo evaluation of sesamol and its derivatives for benign prostatic hypertrophy
por: Shah, Abhishek, et al.
Publicado: (2021)

Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
por: Nath, Chandan Kumar, et al.
Publicado: (2020)

Benign masseter muscle hypertrophy
por: Rispoli, Daniel Zeni, et al.
Publicado: (2015)

Intraurethral Catheter: Alternative Management for Urinary Retention in Patients With Benign Prostatic Hypertrophy
por: Punekar, Sulabha, et al.
Publicado: (1995)

Tamsulosin oral controlled absorption system (OCAS) in the treatment of benign prostatic hypertrophy
por: Neill, Mischel G, et al.
Publicado: (2008)

Retrograde Ejaculation—a Commonly Unspoken Aspect of Prostatectomy for Benign Prostatic Hypertrophy
por: Koren, Gideon, et al.
Publicado: (2020)

Efficacy and safety profile of a novel technique, ThuLEP (Thulium laser enucleation of the prostate) for the treatment of benign prostate hypertrophy. Our experience on 148 patients
por: Iacono, Fabrizio, et al.
Publicado: (2012)

Correlation Between Prostate Volume Measured by Ultrasound and Detrusor Wall Thickness in Men with Benign Prostatic Hypertrophy
por: Ahuizechukwu, Obiesie Emmanuel, et al.
Publicado: (2020)

Preparation, Characterization and Stability Study of Dutasteride Loaded Nanoemulsion for Treatment of Benign Prostatic Hypertrophy
por: Ali, Mohammad Sajid, et al.
Publicado: (2014)

Evaluation of static and dynamic Pupillometry changes in men using Silodosin for benign prostatic hypertrophy
por: Karaca, Umut, et al.
Publicado: (2021)

Inhibitory Activities of Dimeric Ellagitannins Isolated from Cornus alba on Benign Prostatic Hypertrophy
por: Park, Dong-Hui, et al.
Publicado: (2021)

The Butterfly: A Novel Minimally Invasive Transurethral Retraction Device for Benign Hypertrophy of the Prostate
por: Katz, Ran, et al.
Publicado: (2023)

Acute hemorrhagic edema of infancy (AHEI): Alarming cutaneous presentation of a benign and self‐limited disease
por: Tumminello, Mario, et al.
Publicado: (2022)

The differential presence of human polyomaviruses, JCPyV and BKPyV, in prostate cancer and benign prostate hypertrophy tissues
por: Shen, Chenghuang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nahid4vioqhb7d5e2g6f86qo3p